and a strong correlation between urinary cotinine level and FEF 25-75% with a correlation coefficient -0.512. 
Hospital Authority, Hong Kong Background and Aims: The ventilator requires precise setting of parameters to achieve the therapeutic effect, however, the prescription of settings is so complex that difficult for nursing staff to set. To improve the safety and quality of nursing service, pointing and calling (P&C) for checking parameters was introduced to designated area of respiratory ward of M&G of UCH.
a. Enhance quality of patient care by delivering prescribed parameters to patient on IMV and reducing human error. b. Ensure precise prescription of parameters by P&C and early identifying of problem.
c. Enhance nursing staff's confidence in setting the parameters correctly by P&C. Aims
Methods:
a. Set parameters by two nurses with at least one senior nurse following P&C whenever any parameters are modified by doctor. b. Check and record the parameters by two nurses with at least one senior nurse following P&C every shift on specified nursing care report. c. Check and record the parameters by nurse during charting the ventilator chart whenever patient is on IMV support.
d. Encourage junior nurse to seek advice from senior nurse whenever in doubt with the prescribed parameters. e. Clarify with doctor when in physician with the prescribed parameters if necessary. f. Senior coverage by specialty nurse to junior on IMV patient care.
Results: Specified nursing care report and ventilator chart were recorded, indicating that prescribed parameters were delivered accordingly. Nursing staff reported that the use of P&C enhanced alertness and accuracy of setting parameters. Moreover, doubtful prescribed parameters were clarified with physician. No case of belated clarification of prescribed parameters with physician was reported. Junior nurse reported that enhanced confidence in setting parameters IMV.
Conclusion:
No incidence related to discrepancy between prescribed IMV parameters and actual parameters given was reported, which indicating that the implementation of collaborative nursing interventions and P&C improved patient safety. In addition, competency in caring complex IMV patient case of junior nurse was enhanced. Background and Aims: Primary ciliary dyskinesia (PCD) is diagnosed by identifying ultrastructural abnormalities of cilia with transmission electron microscopy (TEM). The mucosal samples obtained for cilia examination are generally procured from the nasal turbinate, but these specimens often yield inadequate results. The bronchial mucosa is recognized as an alternative sample, but no study has examined the utility of bronchial mucosa compared with nasal mucosa in the diagnosis of PCD.
Methods: The medical records of 96 patients who underwent TEM for suspected PCD between April 1997 and June 2017 were retrospectively reviewed. Patients were divided into three groups based on the site of mucosal biopsy: Nasal biopsy group (NB group) with nasal mucosal biopsy only; Bronchial biopsy group (BB group) with bronchial mucosal biopsy only; and Nasal and bronchial biopsy group (NBB group) with a combination of nasal and bronchial mucosal biopsies.
Results: The rate of PCD diagnosis was 28.8% (17/59) in the NB group, 41.2% (7/17) in the BB group, and 60.0% (12/20) in the NBB group. The yield of PCD diagnosis significantly increased in the NBB group compared with the NB group (P = 0.012). In the NBB group, 25%
(5/20) of patients were diagnosed with PCD by nasal mucosal biopsy, and 35% (7/20) of patients were additionally diagnosed with PCD by bronchial mucosal biopsy. The presence of radiologic findings for sinusitis or bronchiectasis was not associated with prediction of PCD diagnosis from nasal or bronchial mucosal biopsy.
The combination of nasal and bronchial mucosal biopsy for TEM showed higher yields of PCD diagnosis than nasal mucosal biopsy alone. 
Ospital ng Makati, Philippines
Background and Aims: Hospital-acquired pneumonia (HAP) is one of the most common nosocomial infections but no recommendation has been established to effectively prevent it among non-intubated patients. Oral chlorhexidine is part of the standard of care among intubated patients in preventing ventilator-associated pneumonia (VAP) but limited studies are available on its benefit among non-intubated patients in preventing HAP. In this study, we performed a randomized controlled trial to investigate the effect of oral chlorhexidine in preventing HAP among nonintubated patients.
Methods:
A prospective randomized open-labeled parallel group controlled trial design was used. 0.12% oral chlorhexidine was given in the treatment group while none was given in the control group. 160 patients were randomized to either treatment (n = 80) or control (n = 80) group. Occurrence of HAP was based on the Centre for Disease Control and Prevention (CDC) criteria.
Results: Overall incidence of HAP is lower among patients with oral chlorhexidine (6.25% vs 12.5%). The duration of hospital stay in the treatment group was shorter than the control group (mean 5.5 days vs mean 6.5 days). The onset of HAP was earlier among patients not receiving oral chlorhexidine (mean 4 days vs mean 9 days). Patients with end stage renal disease, chronic kidney disease, known malignancy, chronic obstructive pulmonary disease, and bronchial asthma are more likely to develop HAP. 
